Studied microRNA gene expression in human hepatocellular carcinoma by microRNA microarray techniques

Area of Science:

• Molecular biology
• Oncology
• Hepatology

Background:

• Hepatocellular carcinoma (HCC) is a significant global health concern.
• Understanding the molecular mechanisms, particularly microRNA (miRNA) expression alterations, is crucial for HCC diagnosis and treatment.
• Hepatitis B virus (HBV) infection is a primary risk factor for HCC development.

Purpose of the Study:

• To investigate the molecular mechanisms of miRNA expression changes in hepatocellular carcinoma.
• To identify specific miRNA signatures associated with HBV-related liver disease progression, including hepatocirrhosis and HCC.
• To understand the role of miRNA alterations in the pathogenesis of HCC.

Main Methods:

• Serum samples were collected from 35 HBV-infected patients (20 with hepatocirrhosis, 15 with HCC) and 12 healthy controls.
• MicroRNA (miRNA) was extracted and analyzed using human V2 miRNA expression beadchip.
• Cluster analysis and radar charts were employed to analyze miRNA expression patterns and identify significant differences between groups.

Main Results:

• Significant differences in miRNA expression were observed between healthy controls, hepatocirrhosis, and HCC groups (P < 0.05).
• miRNA-183 and miRNA-373 showed significant up-regulation, while miRNA-129, miRNA-188, and miRNA-378 exhibited down-regulation.
• The magnitude of miRNA expression changes increased with disease progression from hepatocirrhosis to HCC, suggesting an irreversible process.

Conclusions:

• A significant relationship exists between specific miRNA expression profiles and the incidence of hepatocirrhosis and HCC.
• Irreversible up-regulation of miRNA-183/373 and down-regulation of miRNA-129/188/378 are strongly associated with HBV-related liver cancer.
• These miRNA changes may serve as potential biomarkers for HCC development and progression.